ETV6‐RUNX1, BCR‐ABL1, and TEL‐AML1 were detected in 0% (0/16), 57.1% (12/21), and 6.3% (1/16) of CD304‐positive B‐ALL cases, respectively. Here, RUNX1 is linked to acute lymphoblastic leukemia.